Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Fagus Grandifolia Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of American Beech tree allergies through skin testing and subcutaneous immunotherapy.
Name
Fagus Grandifolia Pollen
Raw Name
FAGUS GRANDIFOLIA POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
20
Variant Count
22
Last Verified
February 17, 2026
About Fagus Grandifolia Pollen
Fagus Grandifolia Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of American Beech tree allergies through skin testing and subcutaneous immunotherapy.
Detailed information about Fagus Grandifolia Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Fagus Grandifolia Pollen.
The American Beech tree is a deciduous hardwood native to eastern North America, stretching from Nova Scotia to Texas. It produces significant quantities of wind-borne pollen during the spring months (typically April to May), which can trigger allergic rhinitis (hay fever) and allergic asthma in sensitized individuals. The extract belongs to a class of drugs called allergenic extracts, which are regulated by the FDA’s Center for Biologics Evaluation and Research (CBER). These extracts have been used in clinical practice for over a century, following the pioneering work of Leonard Noon and John Freeman in 1911, though specific modern formulations of Fagus Grandifolia have been refined through decades of manufacturing improvements.
At the clinical level, Fagus Grandifolia Pollen extract serves as a tool to both provoke and modulate the immune system. When used for diagnostic purposes (skin testing), the extract is introduced into the epidermis or dermis. If the patient has pre-existing IgE (Immunoglobulin E) antibodies specific to American Beech proteins, these antibodies—which are bound to the surface of mast cells—will cross-link upon contact with the allergen. This cross-linking triggers mast cell degranulation, releasing inflammatory mediators such as histamine, leukotrienes, and prostaglandins. The result is a localized 'wheal and flare' reaction (a raised bump surrounded by redness), which confirms the patient's sensitivity.
When used therapeutically in Subcutaneous Immunotherapy (SCIT), the mechanism is far more complex and involves a fundamental 'reprogramming' of the immune system. Initially, the patient is exposed to very low doses of the pollen, which are gradually increased. This process induces several key immunological changes:
As a biological allergenic extract, Fagus Grandifolia Pollen does not follow the traditional ADME (Absorption, Distribution, Metabolism, and Excretion) pathways of small-molecule drugs. Its 'pharmacokinetics' are better understood as the immunological processing of proteins.
Fagus Grandifolia Pollen extract is FDA-approved for the following indications:
Off-label use of these extracts for sublingual immunotherapy (SLIT) is sometimes practiced by specialists using aqueous formulations, though this is not the standard FDA-approved route for non-standardized beech extracts.
> Important: Only your healthcare provider, typically an allergist or immunologist, can determine if Fagus Grandifolia Pollen is right for your specific condition. The selection of the specific extract and concentration requires specialized training in allergy and immunology.
Dosage for Fagus Grandifolia Pollen is highly individualized and must be determined by an allergy specialist based on the patient's sensitivity levels. There is no 'standard' dose for all patients.
Fagus Grandifolia Pollen is generally considered safe for use in children, typically starting at age 5. Dosing protocols for children are identical to adult protocols, though the physician may exercise greater caution during the build-up phase. Because children may have difficulty communicating the early signs of a systemic reaction, they must be monitored even more closely than adults. Use in children under age 5 is generally avoided unless the allergic disease is severe and other options are exhausted.
No dosage adjustments are required for patients with kidney or liver disease, as the extract is processed immunologically rather than through renal or hepatic filtration.
Caution is advised in elderly patients, particularly those with underlying cardiovascular disease. The risk-benefit ratio must be carefully weighed, as the elderly may be less able to tolerate the hemodynamic stress of a systemic reaction (anaphylaxis) or the administration of epinephrine.
Immunotherapy should generally NOT be initiated during pregnancy. However, if a patient is already on a stable maintenance dose and becomes pregnant, the dose is typically maintained or slightly reduced to minimize the risk of a systemic reaction, which could cause fetal hypoxia.
Fagus Grandifolia Pollen extract is administered exclusively by healthcare professionals in a clinical setting equipped to handle emergency reactions.
If a dose is missed during the build-up phase, the next dose may need to be reduced depending on how much time has elapsed:
An 'overdose' in the context of allergenic extracts usually refers to an accidental administration of a concentration higher than the patient's current tolerance level. This is a medical emergency.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not attempt to self-administer these injections or adjust your schedule without medical guidance.
The most common side effects of Fagus Grandifolia Pollen are localized to the site of injection. These are often considered a normal part of the immune response to the extract.
> Warning: Stop taking Fagus Grandifolia Pollen and call your doctor immediately or seek emergency care if you experience any of the following signs of a systemic allergic reaction (anaphylaxis).
There are no known long-term 'toxic' effects of Fagus Grandifolia Pollen extract. Unlike many medications, allergenic extracts do not accumulate in organs or cause chronic damage to the liver or kidneys. The primary long-term risk is the development of a 'large local reaction' which may make continuing therapy uncomfortable. In rare cases, patients may develop a persistent nodule (granuloma) at the injection site if the extract is injected too superficially.
While Fagus Grandifolia Pollen may not have a specific 'branded' black box warning in the way a pharmaceutical pill does, the FDA requires a general Boxed Warning for all allergenic extracts regarding the risk of severe anaphylaxis.
Report any unusual symptoms to your healthcare provider. Even a 'large' local reaction should be reported, as it may be a precursor to a systemic reaction at the next dose.
Fagus Grandifolia Pollen is a potent biological substance. Its use is restricted to diagnostic and therapeutic protocols under the direct supervision of a qualified allergist. Patients must be informed that while the goal of treatment is to reduce allergy symptoms, the treatment itself involves injecting the very substance they are allergic to, which carries inherent risks.
No FDA black box warnings for Fagus Grandifolia Pollen specifically, however, it falls under the class-wide Boxed Warning for all allergenic extracts. This warning emphasizes that these products can cause anaphylaxis, must be administered in a medical setting, and require a 30-minute post-injection observation period. Fatalities have occurred when these precautions were not followed.
The primary risk is a systemic allergic reaction. Risk factors include:
Patients with asthma must have their condition well-controlled before receiving an injection. If a patient is experiencing an asthma flare or has a significantly reduced Peak Flow reading on the day of the injection, the dose should be withheld. Uncontrolled asthma is the single greatest risk factor for a fatal reaction to immunotherapy.
Patients with pre-existing heart conditions are at higher risk if a systemic reaction occurs. The physiological stress of anaphylaxis, combined with the potential need for high-dose epinephrine (which increases heart rate and blood pressure), can trigger arrhythmias or myocardial infarction (heart attack).
Generally, Fagus Grandifolia Pollen does not cause sedation. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until they have been cleared by a medical professional and have fully recovered from the event.
Alcohol should be avoided for several hours before and after an injection. Alcohol causes vasodilation (widening of blood vessels), which can speed up the absorption of the allergen and potentially increase the risk or severity of a systemic reaction.
Immunotherapy can be discontinued at any time, but the benefits (allergy protection) will gradually fade. If therapy is stopped for more than a few weeks and then restarted, the doctor must significantly reduce the dose to ensure safety.
> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Fagus Grandifolia Pollen.
For each major interaction, the mechanism is usually pharmacodynamic (affecting how the body responds to the drug or the emergency treatment) rather than pharmacokinetic (affecting how the drug is broken down).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including eye drops and over-the-counter cold medicines.
Patients allergic to Fagus Grandifolia Pollen often show cross-reactivity with other members of the Fagaceae family, which includes Oaks (Quercus) and Chestnuts (Castanea). If you are severely allergic to Oak, you may have a stronger-than-expected reaction to Beech extract. Your doctor will use this information to choose a safe starting dose.
> Important: Your healthcare provider will evaluate your complete medical history, including your lung function and heart health, before prescribing Fagus Grandifolia Pollen.
FDA Pregnancy Category C. There are no adequate and well-controlled studies of Fagus Grandifolia Pollen in pregnant women.
It is not known whether the components of Fagus Grandifolia Pollen extract are excreted in human milk. However, because the extract consists of naturally occurring proteins that are processed locally and in the lymph nodes, it is highly unlikely that any significant amount reaches the breast milk. Breastfeeding is generally considered safe during immunotherapy.
Patients over age 65 require a thorough cardiovascular evaluation. The elderly are more likely to be taking medications (like beta-blockers or ACE inhibitors) that complicate allergy treatment. Additionally, the 'immune senescence' (aging of the immune system) may make immunotherapy slightly less effective in older adults compared to younger patients.
No specific studies have been conducted in patients with renal impairment. However, since the proteins are degraded by cellular proteases and not excreted by the kidneys, no dose adjustment is typically necessary. Patients on dialysis should still be monitored for hemodynamic stability.
Liver disease does not affect the processing of allergenic extracts. No dose adjustments are required for patients with any Child-Pugh classification of hepatic impairment.
> Important: Special populations require individualized medical assessment. Always inform your allergist if you become pregnant or develop a new medical condition during the course of treatment.
Fagus Grandifolia Pollen extract acts as an immunomodulator. In a sensitized individual, the 'default' response to beech pollen is the production of Th2 cytokines (IL-4, IL-5, IL-13), which stimulate B-cells to produce IgE. The extract, when administered in increasing doses, induces Peripheral Tolerance. This is achieved by:
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Local) |
| Protein Binding | Primarily to IgE and IgG antibodies |
| Half-life | Proteins degraded within hours to days |
| Tmax | 15-30 minutes (for local reaction) |
| Metabolism | Cellular Proteolysis |
| Excretion | Not renally/fecally excreted |
Fagus Grandifolia Pollen belongs to the class of Allergenic Extracts. It is specifically a Non-Standardized Tree Pollen Extract. Related medications include extracts for Oak, Birch, and Hickory, which are often mixed together in a 'Tree Mix' for patient convenience.
Common questions about Fagus Grandifolia Pollen
Fagus Grandifolia Pollen extract is primarily used for the diagnosis and treatment of allergies to the American Beech tree. In a clinical setting, an allergist uses a small amount of the extract to perform a skin prick test, which confirms if a patient's immune system reacts to beech pollen. If a significant allergy is found, the extract can then be used in 'allergy shots' (immunotherapy) to help the body build up a tolerance. Over time, this treatment reduces symptoms like sneezing, itchy eyes, and asthma caused by beech trees. It is an essential tool for patients who do not get enough relief from standard allergy medications.
The most frequent side effects are localized reactions at the site where the extract was injected or applied to the skin. This typically includes redness, itching, and a raised bump or swelling that looks like a mosquito bite. These reactions usually appear within minutes and fade within a few hours, though some 'late-phase' swelling can occur up to 24 hours later. Systemic side effects, such as hay fever symptoms or fatigue, are less common but can occur. Because there is a small risk of a severe allergic reaction (anaphylaxis), all injections must be given in a doctor's office. Your provider will monitor you for at least 30 minutes to ensure your safety.
It is strongly recommended that you avoid alcohol on the days you receive Fagus Grandifolia Pollen injections. Alcohol can cause your blood vessels to dilate and increase blood flow to the skin, which may cause the allergen extract to be absorbed into your system more quickly than intended. This rapid absorption can increase the risk of a systemic allergic reaction or make a local reaction more severe. Furthermore, alcohol can mask the early symptoms of a reaction or interfere with the medications used to treat an emergency. It is best to wait at least 24 hours after your injection before consuming alcohol. Always follow the specific lifestyle guidance provided by your allergy specialist.
Fagus Grandifolia Pollen is generally not started during pregnancy because the risk of a severe allergic reaction (anaphylaxis) could harm the developing fetus by reducing oxygen supply. However, if a woman is already on a stable 'maintenance' dose of allergy shots and becomes pregnant, most allergists will continue the treatment. In these cases, the dose is usually kept the same or slightly reduced to ensure the mother's allergies remain controlled without increasing the risk of a reaction. The decision to continue therapy is made on a case-by-case basis by weighing the benefits of allergy control against the risks. Always inform your doctor immediately if you become pregnant while receiving these injections.
The timeline for Fagus Grandifolia Pollen immunotherapy is a long-term commitment. While a skin test provides results in about 20 minutes, the therapeutic benefits of allergy shots take much longer to manifest. Most patients begin to notice a decrease in their allergy symptoms during the first 'maintenance' year, which is typically 6 to 12 months after starting the build-up phase. Maximum benefit is usually reached after 2 to 3 years of consistent treatment. A full course of therapy typically lasts 3 to 5 years, which can provide long-lasting relief even after the injections are stopped. It is important not to get discouraged if you do not feel better within the first few weeks.
Yes, you can stop taking Fagus Grandifolia Pollen injections at any time without experiencing 'withdrawal' symptoms like you might with some chemical drugs. However, stopping the treatment prematurely will likely result in the return of your original allergy symptoms, as your immune system has not had enough time to develop long-term tolerance. If you stop for a short period (weeks) and wish to restart, your doctor will need to reduce your dose significantly to safely build back up. If you stop for several months, you may need to restart the entire process from the beginning. Always discuss your plans with your allergist before interrupting your treatment schedule.
If you miss a scheduled dose of Fagus Grandifolia Pollen, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to 'double up' on your next dose or take an injection at home. The safety of immunotherapy depends on a specific schedule; if too much time passes between injections, your level of tolerance may drop. Depending on how many days or weeks have passed, your doctor may give you the same dose you had last time, or they may need to reduce the dose slightly to prevent a reaction. Consistency is key to both the safety and the effectiveness of the treatment.
There is no scientific evidence or clinical data suggesting that Fagus Grandifolia Pollen extract causes weight gain. The extract consists of natural proteins and a small amount of stabilizer (like glycerin or phenol), none of which affect metabolism, appetite, or fat storage. If you experience weight changes while on immunotherapy, it is likely due to other factors, such as other medications (like oral steroids sometimes used for severe allergies) or changes in lifestyle. If you have concerns about weight gain, you should discuss them with your primary care physician to identify the underlying cause.
Fagus Grandifolia Pollen can be taken alongside most common medications, but there are some critical exceptions. You must inform your doctor if you are taking beta-blockers (used for blood pressure, heart rhythm, or glaucoma), as these can make a severe allergic reaction much harder to treat. ACE inhibitors and certain antidepressants (MAOIs) can also increase the risk or severity of reactions. Most standard allergy medications, like antihistamines and nasal sprays, are fine to use and are often encouraged to help manage symptoms during the build-up phase. Always provide your allergist with a complete and updated list of all medications and supplements you are using.
The concept of 'generic' vs. 'brand name' works differently for allergenic extracts like Fagus Grandifolia Pollen. These are biological products, and while several different laboratories (such as Greer, HollisterStier, or ALK) may produce American Beech extract, they are not considered 'generics' of one another. Each manufacturer has its own proprietary process for collecting and extracting the pollen. Because these are non-standardized extracts, a 1:20 w/v solution from one company may not have the exact same potency as a 1:20 w/v solution from another. Therefore, allergists usually stick with one manufacturer for a patient's entire course of treatment to ensure consistency and safety.